Canary Speech pricing
Cost is absent from every published surface: no pricing page, no unit of charge, no range, no volume tiering, no implementation fee position, no minimum commitment and no trial terms. Sales start from a demo request.
How Canary Speech pricing works
- Pricing model
- Not disclosed. No unit of charge is described anywhere. Whether pricing runs per analysis, per minute of speech, per monitored individual, per seat, by annual license or by usage tier is unstated, and the interface first architecture means the natural unit is a call or a completed assessment rather than a user, so the basis cannot be inferred from the product shape as it sometimes can. Nothing indicates how the continuous monitoring offering is charged relative to episodic assessment, nor whether the cognitive and behavioral models are licensed separately.
- Implementation
- Not disclosed. No implementation, integration or onboarding fee is published, and no deployment timeline. The likely effort can be characterized from the architecture even though it is never costed: an interface first product shifts integration work onto the customer or partner, who builds the surrounding application, handles audio capture and decides how results are presented. Whether Canary charges for integration support, certification of a partner implementation, or model tuning against a customer population is unstated, as is whether the institutional review board approved study work with a health system partner represents a funded engagement or a research collaboration.
- Business associate agreement
- Not disclosed as a template or posture, and complicated by the embedded model. HIPAA compliance is asserted as full, with anonymous configurations offered and application programming interface research data described as de identified in the analysis environment, which can mean the vendor holds no identity at all in some deployments. Which deployments run that way is not stated. No business associate agreement template, negotiation stance or execution requirement is published. The contracting chain is the distinctive point: when the analysis runs inside a partner's product and the patient relationship belongs to that partner, whether Canary signs as a business associate directly with covered entities or as a subcontractor to the integrator is unstated, and that determines who carries breach notification duties. Separately, a voiceprint is biometric data regulated in some jurisdictions under statutes distinct from health privacy law, with their own consent and retention requirements, and nothing published engages that regime.
The single commercial adjective published is that the offering is cost effective, given without a figure, a comparison or a basis, which is a claim a buyer cannot act on or verify.
For an interface first product the omission matters more, not less. Usage priced infrastructure has an obvious, inspectable unit of consumption: a call, a minute of audio, a completed assessment. An integration partner has to model cost of goods sold before committing engineering effort to embed a third party model in its own product, and that calculation cannot begin without a unit price.
Segment spread compounds it. A health system, a payer, a pharmaceutical sponsor running a trial, an employer, a clinical call center and a consumer caregiving application cannot plausibly share a single rate. Continuous monitoring in particular implies a fundamentally different consumption profile from episodic assessment, and the continuous variant is marketed as a distinct offering without any indication of how it is charged. Whether consumer and pharmaceutical embedding carry separate rates is not stated.
No return proxy is supplied either. The commercial argument rests on earlier detection of behavioral and cognitive change, and no cost per assessment, cost per case identified, or avoided cost figure is published to support it. The market sizing claims that appear instead, including a stated multi trillion dollar savings opportunity from early detection of cognitive illness, describe a category rather than a customer's economics.
Canary Speech pricing against its alternatives
Published prices for Canary Speech and the products closest to it. Each figure is as the vendor publishes it, in its own currency and billing unit.
- CCanary SpeechNo published price
- VVidera HealthNo published price
- WWysaConsumer product free with paid premium tier, enterprise pricing not published
- AAiberry$5,000/year (Digital MindCare, annual organizational license, no usage limits), with Smart AI MindCare and Custom Enterprise quoted
- EEllipsis HealthNo published price
- NNeuroFlowNo published price
- CCallyopeNo published price
- EEleos HealthNo published price
- SSpring HealthNo published price
Canary Speech pricing, answered
How much does Canary Speech cost?
Canary Speech does not publish a price. Cost is absent from every published surface: no pricing page, no unit of charge, no range, no volume tiering, no implementation fee position, no minimum commitment and no trial terms. Sales start from a demo request.
Does Canary Speech charge an implementation fee?
Not disclosed. No implementation, integration or onboarding fee is published, and no deployment timeline. The likely effort can be characterized from the architecture even though it is never costed: an interface first product shifts integration work onto the customer or partner, who builds the surrounding application, handles audio capture and decides how results are presented. Whether Canary charges for integration support, certification of a partner implementation, or model tuning against a customer population is unstated, as is whether the institutional review board approved study work with a health system partner represents a funded engagement or a research collaboration.
Does Canary Speech offer a business associate agreement?
Not disclosed as a template or posture, and complicated by the embedded model. HIPAA compliance is asserted as full, with anonymous configurations offered and application programming interface research data described as de identified in the analysis environment, which can mean the vendor holds no identity at all in some deployments. Which deployments run that way is not stated. No business associate agreement template, negotiation stance or execution requirement is published. The contracting chain is the distinctive point: when the analysis runs inside a partner's product and the patient relationship belongs to that partner, whether Canary signs as a business associate directly with covered entities or as a subcontractor to the integrator is unstated, and that determines who carries breach notification duties. Separately, a voiceprint is biometric data regulated in some jurisdictions under statutes distinct from health privacy law, with their own consent and retention requirements, and nothing published engages that regime.